XENE vs SEB

Comparison between Xenon Pharmaceuticals Inc (XENE, Company) and Seaboard Corp (SEB, Company).

XENE is from the Healthcare sector, while SEB is from the Industrials sector.

5-Year PerformanceXENE has outperformed SEB, delivering a return of +22.9% compared to +7.4%

XENE vs SEB - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	XENE(COMPANY)	SEB(COMPANY)
Market Cap	$4.96B	$4.96B
Max Drawdown	90.43%	70.28%
Sharpe Ratio	1.00	1.86
5Y Beta	0.95	0.26
Industry	Biotechnology	Conglomerates
P/E Ratio	-11.03	8.42
Forward P/E	N/A	11.93
PEG Ratio	-0.27	0.02
Dividend Yield	N/A	0.17%
5Y Dividends CAGR	N/A	0.00%
5Y EPS CAGR	40.27%	4.77%
Debt to Equity	0.00%	18.25%
Free Cash Flow Yield	-6.19%	-0.30%
P/S Ratio	727.44	0.51
P/B Ratio	3.81	0.93

Market Cap

Winner

XENE

$4.96B

SEB

$4.96B

Max Drawdown

XENE

90.43%

Winner

SEB

70.28%

Sharpe Ratio

XENE

1.00

Winner

SEB

1.86

5Y Beta

XENE

0.95

Winner

SEB

0.26

Industry

XENE

Biotechnology

SEB

Conglomerates

P/E Ratio

Winner

XENE

-11.03

SEB

8.42

Forward P/E

XENE

N/A

SEB

11.93

PEG Ratio

Winner

XENE

-0.27

SEB

0.02

Dividend Yield

XENE

N/A

SEB

0.17%

5Y Dividends CAGR

XENE

N/A

SEB

0.00%

5Y EPS CAGR

Winner

XENE

40.27%

SEB

4.77%

Debt to Equity

Winner

XENE

0.00%

SEB

18.25%

Free Cash Flow Yield

XENE

-6.19%

Winner

SEB

-0.30%

P/S Ratio

XENE

727.44

Winner

SEB

0.51

P/B Ratio

XENE

3.81

Winner

SEB

0.93

XENE vs SEB - Historical Returns

Returns include dividend reinvestment.

Period	XENE	SEB
1 month	-5.27%	+14.65%
3 months	-10.02%	+6.47%
6 months	+18.25%	+20.38%
1 year	+58.84%	+93.85%
5 years(CAGR)	+22.87%	+7.38%
10 years(CAGR)	+21.88%	+6.86%
Max(CAGR)	+14.81%	+12.92%

XENE

-5.27%

Winner

SEB

+14.65%

XENE

-10.02%

Winner

SEB

+6.47%

XENE

+18.25%

Winner

SEB

+20.38%

XENE

+58.84%

Winner

SEB

+93.85%

5Y(CAGR)

Winner

XENE

+22.87%

SEB

+7.38%

10Y(CAGR)

Winner

XENE

+21.88%

SEB

+6.86%

Max(CAGR)

Winner

XENE

+14.81%

SEB

+12.92%

XENE vs SEB - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	XENE	SEB
2026	+17.10%	+20.33%
2025	+11.58%	+84.04%
2024	-12.71%	-32.31%
2023	+23.62%	-2.62%
2022	+24.82%	-2.97%
2021	+111.94%	+26.44%
2020	+12.10%	-28.14%
2019	+96.26%	+21.67%
2018	+119.48%	-18.95%
2017	-64.01%	+10.09%
2016	-3.27%	+40.64%
2015	-57.01%	-29.37%
2014	+88.10%	+51.98%
2013	N/A	+5.76%
2012	N/A	+18.81%
2011	N/A	+1.65%
2010	N/A	+43.52%
2009	N/A	+11.33%
2008	N/A	-18.97%
2007	N/A	-16.35%
2006	N/A	+19.10%
2005	N/A	+51.45%
2004	N/A	+257.30%
2003	N/A	+18.03%
2002	N/A	-25.90%
2001	N/A	+103.63%
2000	N/A	-21.56%
1999	N/A	-14.68%

XENE vs SEB Drawdown Comparison

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The maximum drawdown for SEB was -70.20%, occurring on Nov 20, 2008. Recovery took 1072 trading sessions.

The current XENE drawdown is -16.99%. The current SEB drawdown is -10.72%.

Rank	XENE	SEB
#1	-90.43% Jan 8, 2015 - Oct 4, 2021	-70.20% Apr 20, 2007 - Jul 21, 2011
#2	-43.59% Feb 9, 2024 - Mar 9, 2026	-48.37% Apr 23, 2019 - Nov 26, 2025
#3	-34.08% May 9, 2023 - Dec 22, 2023	-46.49% Mar 20, 2015 - Oct 12, 2017
#4	-30.14% Nov 5, 2021 - Aug 4, 2022	-40.47% Nov 8, 1999 - Jul 12, 2001
#5	-25.87% Nov 11, 2014 - Dec 11, 2014	-39.31% Jan 9, 2002 - Feb 9, 2004
#6	-18.40% Mar 9, 2026 - Jun 8, 2026	-37.72% Jul 21, 2011 - Jan 29, 2013
#7	-17.08% Mar 1, 2023 - May 3, 2023	-36.88% Dec 5, 2005 - Jan 8, 2007
#8	-16.98% Aug 24, 2022 - Feb 13, 2023	-34.02% Jul 8, 2005 - Dec 5, 2005
#9	-11.44% Oct 15, 2021 - Nov 2, 2021	-32.14% Aug 13, 2001 - Dec 7, 2001
#10	-11.09% Dec 11, 2014 - Dec 29, 2014	-31.44% Apr 12, 2005 - May 20, 2005
#11	-9.36% Feb 13, 2023 - Mar 1, 2023	-24.65% Oct 12, 2017 - Apr 18, 2019
#12	-8.58% Jan 8, 2024 - Feb 8, 2024	-24.03% Apr 9, 2026 - May 7, 2026
#13	-8.27% Aug 10, 2022 - Aug 24, 2022	-20.00% Aug 5, 2013 - Jun 24, 2014
#14	-6.08% Dec 29, 2014 - Jan 7, 2015	-19.93% Jul 1, 2014 - Nov 4, 2014
#15	-4.89% Dec 27, 2023 - Jan 8, 2024	-15.88% Sep 21, 2004 - Oct 27, 2004